Indivior Pharmaceuticals (INDV) Current Taxes (2021 - 2025)
Historic Current Taxes for Indivior Pharmaceuticals (INDV) over the last 5 years, with Q3 2025 value amounting to $4.0 million.
- Indivior Pharmaceuticals' Current Taxes rose 14444.44% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year increase of 14444.44%. This contributed to the annual value of $7.0 million for FY2024, which is 1250.0% down from last year.
- As of Q3 2025, Indivior Pharmaceuticals' Current Taxes stood at $4.0 million, which was up 14444.44% from $17.0 million recorded in Q2 2025.
- In the past 5 years, Indivior Pharmaceuticals' Current Taxes registered a high of $17.0 million during Q2 2025, and its lowest value of -$9.0 million during Q3 2024.
- Moreover, its 5-year median value for Current Taxes was $5.5 million (2021), whereas its average is $2.5 million.
- In the last 5 years, Indivior Pharmaceuticals' Current Taxes plummeted by 8000.0% in 2024 and then soared by 31250.0% in 2025.
- Quarter analysis of 5 years shows Indivior Pharmaceuticals' Current Taxes stood at $7.0 million in 2021, then rose by 28.57% to $9.0 million in 2022, then decreased by 11.11% to $8.0 million in 2023, then dropped by 12.5% to $7.0 million in 2024, then tumbled by 42.86% to $4.0 million in 2025.
- Its Current Taxes stands at $4.0 million for Q3 2025, versus $17.0 million for Q2 2025 and $12.0 million for Q1 2025.